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Abstract
Different causative factors acting on the pancreas can 
result in diseases such as pancreatitis, diabetes and 
pancreatic tumors. The high incidence and mortality of 
pancreatic diseases have placed diagnostic imaging in 
a crucial position in daily clinical practice. In this mini-
review article different pancreatic imaging techniques 
are discussed, from the standard clinical imaging mo-
dalities and state of the art clinical magnetic resonance 
imaging techniques to current situations in pre-clinical 
pancreatic imaging studies. In particular, the challenges 
of pre-clinical rodent pancreatic imaging are addressed, 
with both the image acquisition techniques and the 
post-processing methods for rodent pancreatic imaging 
elaborated. 
Key words: Pancreatic imaging; Rats; State of the art 
clinical magnetic resonance imaging; 3.0T scanner; 
Quantitative magnetic resonance imaging
© The Author(s) 2017. Published by Baishideng Publishing 
Group Inc. All rights reserved.
Core tip: In this minireview, the challenges of pre-
clinical rodent pancreatic imaging are addressed, basic 
clinical magnetic resonance imaging techniques and 
post-processing methods for rodent pancreatic imaging 
are also elaborated.
Yin T, Liu Y, Peeters R, Feng Y, Ni Y. Pancreatic imaging: 
Current status of clinical practices and small animal studies. 
World J Methodol 2017; 7(3): 101-107  Available from: URL: 
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INTRODUCTION
The pancreas is an important visceral organ performing 
both endocrine and exocrine functions. Abnormalities 
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of the pancreas result in diseases such as pancreatitis, 
diabetes, and pancreatic tumors[1,2]. The onset of 
diabetes is usually long after beta cell dysfunction and 
insulin resistance[3,4]; pancreatic cancer is generally 
asymptomatic and frequently diagnosed at a late 
stage[5]; acute pancreatitis is a painful inflammatory 
condition often with severe complications and high 
mortality despite treatment[6], while chronic pancreatitis 
can mimic the symptoms of pancreatic cancer and lead 
to misdiagnosis[7]. The high incidence of pancreatitis 
and diabetes, and poor survival rate of pancreatic 
cancers have increased the demand for new diagnostic 
and therapeutic strategies[8,9] Herein multimodality 
multi-parametric imaging plays an indispensable role 
in disease detection, therapy guidance and patient 
follow-up. In this mini-review, current situations of 
common clinical practices and recent development of 
pre-clinical rodent studies in pancreatic imaging are 
inspected and discussed with the emphasis on basic 
magnetic resonance imaging (MRI) techniques and 
post-processing methods for rodent pancreatic studies. 
OVERVIEW OF CLINICAL IMAGING 
MODALITIES
Ultrasound
As an initial step, abdominal ultrasound is most com-
monly used in screening for biliary stones and tumors, 
as this equipment is widely available at relatively low 
costs[10]. However, the quality of ultrasound images 
and diagnostic accuracy are highly user-dependent, 
and the retroperitoneal location of the pancreas may 
impose image artifacts and hamper the ultrasound 
diagnosis[11]. For further confirmation and staging of 
pancreatic diseases, imaging modalities with higher 
quality and sensitivity are needed. 
Computed tomography 
Contrast-enhanced multi-detector computed tomo-
graphy (MDCT) remains the standard modality in clinic 
for the assessment of pancreatitis and pancreatic 
cancer[12,13]. Due to its high spatial resolution and 
fast image acquisition, MDCT combined with contrast 
agents injection, has shown its powerful capacity in the 
staging of pancreatitis and pancreatic cancer with high 
sensitivity and specificity[7,12]. 
MRI
MRI as a non-ionizing imaging modality has been 
increasingly utilized in clinic due to its multi-parametric 
capability[14]. With the constant improvement of 
the new MRI hardware and imaging reconstruction 
algorithms, MRI is currently capable of acquiring 
images of spatial resolution approaching to that of CT. 
Meanwhile, with the application of accelerated parallel 
imaging techniques, most MRI protocols have the 
feasibility to be accomplished in one or a few breath-
holds[14,15]. 
Traditionally, T2-weighted MRI sequences are 
commonly used to provide structural information on 
the anatomy of the pancreatic ductal system and 
lesions[14]. MR cholangiopancreatography (MRCP) using 
heavily T2-weighted sequences has been widely applied 
as non-invasive alternative to endoscopic retrograde 
cholangiopancreatography (ERCP) for biliopancreatic 
duct system evaluation[16]. The combination of dual-
echo (in/opposed-phase) T1-weighted MRI sequences 
is useful for hemorrhage and fat content assessment[14]. 
Dynamic contrast-enhanced (DCE) MRI scans are 
performed for differential diagnosis and grading of solid 
pancreatic lesions and pancreatitis by analyzing the 
pharmacokinetic parameters or contrast concentration 
curves[17,18]. In addition, diffusion-weighted MRI (DWI) 
protocols have also shown a great potential to depict 
and characterize pancreatic diseases including acute/
chronic pancreatitis and benign or malignant tumors[19] 
without a need to use contrast agents. 
Other more advanced but less popular pancreatic 
imaging modalities, often with a certain invasiveness 
or radiation exposure, include endoscopic and contrast 
enhanced US (EUS and CEUS), positron emission 
computed tomography and single-photon emission 
computed tomography incorporated with X-ray based 
CT (PET/CT and SPECT/CT) for improved spatial 
resolution and co-localization of imaging findings, 
etc. For a more comprehensive overview, a recent 
review article about imaging pancreatic diseases is 
recommended[5].
CURRENT STATUS OF RODENT 
PANCREATIC IMAGING
Challenges in rodent pancreatic imaging
In order to develop new diagnostic and therapeutic 
strategies against pancreatic diseases, rodent models 
are commonly used in preclinical studies. However, imag-
ing the pancreas in rodents proves to be extremely 
challenging due to motion artifacts and uncertain 
anatomy. The pancreas in humans represents a retro-
peritoneal solid organ, which can be identified by 
imaging modalities even without contrast enhance-
ment, as stated above. However, unlike the human 
pancreas, the rodent pancreas appears as a soft, 
diffuse and irregularly lobulated organ, which is very 
difficult to discern from surrounding tissues[19-22], even 
during open abdominal surgery (Figure 1). Pancreas-
specific contrast agents would facilitate pancreas 
visualization, but currently those pancreatic specific 
markers are unavailable yet. Without specific labeling, 
rodent caudate liver lobes and abdominal fat tissue 
are frequently identified as pancreas by mistake. In 
some animal studies, pancreas associated injuries in 
other solid organs, instead of the pancreas itself, were 
investigated using contrast-enhanced protocols and MR 
spectroscopy (MRS)[23,24]. 
Three dimensional pancreatic imaging
To avoid the misdiagnosis and to have a detailed 
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overview of the pancreas anatomy, two pancreatic 
imaging studies were performed using contrast-
enhanced high-resolution three dimensional (3D) mo-
dalities to provide more precise anatomical information 
of the rodent pancreas[20,22]. In a micro-CT study[20], 
the in vivo rat pancreatic tail portion could be identified 
after a two-step contrast injection. Unlike the human 
pancreas that can be readily depicted by MRI even 
without using any contrast agent (Figure 2), detailed 
3D rodent pancreatic anatomy and surrounding land-
marks could only be demonstrated (Figure 2) by 
biliopancreatic local infusion of mixed contrast media in 
a post-mortem model[22].
Diabetes imaging 
In order to achieve early diagnosis in diabetes, the 
development of pancreatic specific contrast agents 
became a hot topic. Among others, some contrast 
agents were used to target pancreatic beta cells 
for diabetes related research subjects, for instance, 
glucagon-like peptide-1 (GLP1) receptor and GLP1 
analogues have been frequently studied in rodent 
diabetes imaging[25,26]. The micro-vascular changes in 
case of diabetes and pancreatic inflammation were 
also investigated[27,28]. 
Pancreatitis imaging 
The first attempt of rodent pancreatitis imaging started 
during the 1980’s, conducted by Paajanen et al[29], in 
which Gd-DTPA was applied as a contrast agent for T2/
T1 relaxation measurements in an acute hemorrhagic 
pancreatitis model. In 1989, Kushnir et al[30] performed 
several MRS experiments to identify imaging bio-
markers in an acute pancreatitis model. More recently, 
specific nanoparticles were developed for pancreatitis 
imaging, with lipase as the target[31]. Imaging of acute 
edematous pancreatitis can also be performed with 
MRCP, T2 relaxation measurement and non-specific 
contrast enhancement using modified protocols on a 
state of the art clinical MRI scanner[32]. 
Pancreatic tumor imaging
The direct visualization of rodent pancreas and 
corresponding pancreatic landmarks could facilitate 
more precise diagnosis of a pancreatic tumor in the 
early stages. As a tumor grows to a certain volume, the 
identification of the solid tumor mass is much easier 
to perform than imaging other pancreatic disorders. 
Quantitative T2 and T1 relaxation measurements, 
DWI parameters and perfusion information can be 
obtained using multi-parametric MRI[33]. Currently, 
rodent pancreatic tumor models are increasingly used 
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Figure 2  Typical human pancreatic magnetic resonance imaging vs 
rodent pancreatic magnetic resonance imaging. The upper transverse 
image shows the human pancreas (contoured by arrowheads) as a solid organ 
adjacent to the liver (L), gallbladder (G), spleen (S), kidney (K) and small 
intestines (I). The lower 3-D images display the coronal (left), transverse (mid) 
and sagittal (right) views of the contrast-infused rat pancreas with green color 
coding, adjacent to the liver (L), spleen (S), kidney (K) and colon (C). MRI: 
Magnetic resonance imaging.
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Figure 1  Anatomical difference between human and rodent pancreas. 
Unlike the human pancreas which is a well-defined solid organ (A), the rat 
pancreas appears as a soft, diffuse and irregularly lobulated organ (B), which 
is very difficult to discern from surrounding tissues even at open abdominal 
surgery. To better visualize it, the pancreatic ductal system was infused with 
Evans blue dye while the arterial system was injected with a barium sulphate 
suspension. 
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Basic clinical MRI techniques for rodent pancreatic 
imaging
In our serial studies[22,32,33], clinical scanners were 
used for pancreatic imaging: The Magnetom Tim Trio 
(Siemens, Erlangen, 45 mT/m, 200 T/m per second) 
combined with an 8-channel wrist coil; and the Mag-
netom Prisma (Siemens, Erlangen, 80 mT/m, 200 
T/m per second) together with a 16-channel wrist coil. 
There are several standard clinical protocols which can 
be directly translated to pre-clinical research, including 
T2-weighted 3D turbo spin-echo (TSE) based SPACE 
(3D TSE with variable-flip-angle refocusing RF pulses) 
imaging and MRCP protocols, standard 2D multi-echo 
spin-echo sequences for T2 relaxation, as well as 
diffusion and perfusion sequences. The animal models 
introduced in these studies[22,32,33] are a rat acute 
pancreatitis model and a rat orthotopic pancreatic 
tumor model, in which we intended to characterize 
pathological changes including edema, hemorrhage 
and necrosis by those modified MRI methods.
Three-dimensional volumetric images: As 
mentioned above, 3D imaging would facilitate the 
localization of rodent pancreas. The other benefit is 
the possibility of volumetric measurements in 3D. 
In case of edematous pancreatitis, edema volume 
is a biomarker for pancreatitis. Meanwhile, 3D views 
could also provide a more accurate measurement for 
irregularly shaped abdominal tumors (Figure 2). The 
volume of the target tissue can be obtained from post-
process image segmentation. The most important 3D 
imaging protocols used here are T2-weighted SPACE 
and MRCP, which are also widely used in clinical MRI 
abdominal examinations. 
Quantitative MRI measurements: Quantitative 
MRI relaxation measurements are useful in organ/
tissue characterization. T2 mapping is helpful in the 
assessment of fluid content and hemorrhage; and 
native T1 mapping is essential for the calculation of the 
tissue concentration time curve (CTC) in DCE protocols. 
In these studies, mono-exponential T2 mapping and 
inversion recovery based T1 mapping were performed. 
Measurements of Gaussian and non-Gaussian 
diffusion for water in biological tissues can be accom-
plished using DWI with different combinations of 
diffusion weightings. Mean diffusivity and diffusion 
kurtosis were obtained from 3-trace diffusion images.
Moreover, tissue perfusion can be characterized 
using DCE protocols, after the injection of a gadolinium 
based MRI contrast agent. After the signal conversion 
to gadolinium concentration using pre-contrast native 
T1 relaxation information, either semi-quantitative 
information or quantitative parameters from the phar-
macokinetic Tofts model were extracted. Detailed MRI 
protocol parameters are elaborated in the different 
serial studies[22,32,33]. 
to investigate new therapeutic strategies in longitudinal 
follow-up studies by non-invasive MRI. 
RODENT PANCREATIC IMAGING USING 
A CLINICAL MRI SCANNER
Rationale behind the use of a clinical MRI scanner for 
rodent pancreatic research
Due to the small size of the rodent pancreas, it is 
necessary to use high resolution 3D anatomical 
images for precise pancreas localization. Misdiagnosis 
could be avoided by carefully tracking the anatomy 
of the surrounding organs or tissues in 3D mode. 
Unfortunately, 3D anatomical MRI in the abdominal 
region is extremely challenging in commonly used 
high-field pre-clinical scanners, due to their high sen-
sitivity to motion artifacts at high magnetic field and 
unavoidable long scanning durations. Alternatively, by 
the combined use of dedicated multi-channel coils and 
accelerated parallel imaging, clinical MR scanners have 
shown the feasibility and flexibility for rodent abdominal 
imaging[22,32,33]. 
Limits and benefits of clinical scanners
The biggest problem using clinical scanners for small 
animal studies is the limited gradient strength[34]. Most 
clinical MRI scanners have a gradient amplitude of 
40 mT/m and slew rates up to 200 T/m per second. 
Although the maximum gradient amplitude in the 
recent 3T Siemens Prisma scanner has been increased 
to 80 mT/m, the gradient strengths are still up to 10 
times lower than that of the current state of the art 
pre-clinical scanners. Consequently, the minimum 
slice thickness and minimal field of view (FOV) in the 
clinical systems are more restricted. In our studies, to 
maintain enough signal-to-noise-ratio (SNR), most 2D 
scans were performed with a slice thickness of 2 mm, 
which is identical to those acquired from small animal 
scanners. However, the minimal FOV is usually limited 
to around 70 mm. The limited gradient strengths also 
hamper the use of echo planar imaging (EPI) due to 
the prolonged readout, which leads to severe image 
distortions. 
On the other hand, current state of the art clinical 
MRI scanners provide an excellent hardware stability, 
higher field homogeneity and a dedicated user in-
terface, and are more widely accessible compared 
to small animal scanners. With the combination of 
dedicated clinical multi-channel surface coils and the 
self-calibrated parallel imaging techniques GRAPPA 
(GeneRalized Autocalibrating Partial Parallel Acquisition), 
it is possible to acquire high SNR images in rodent 
heterogeneous abdominal region with a sufficiently 
short scan duration. Moreover, lower magnetic field and 
application of GRAPPA provide a higher feasibility to 
rodent abdominal imaging. 
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Data processing
In these studies, open-source software and in-house 
built programs were used for data processing. This 
includes image segmentation, registration and 3D 
image visualization in open-source software ITK-
SNAP (www.itksnap.org) and MeVisLab (MeVis Medical 
Solutions, Bremen, Germany); DICOM process, MRI 
mathematical modeling and quantitative analysis in 
Matlab programs (MathWorks, Natick, Massachusetts); 
and statistical analysis and data visualization using 
programs combining both Matlab and R (https://cran.
r-project.org). Detailed image processing equations 
are included in the next section. 
SOME OF THE ONGOING RESEARCH IN 
RODENT PANCREATIC MRI STUDIES
Identified objectives 
Present research project aims at providing practical 
solutions to rodent pancreatic imaging using clinical 
facilities, from ex vivo to noninvasive in vivo imaging 
with the following systematic objectives identified: (1) 
To overcome the limitations of clinical MRI scanner for 
small rodent imaging studies; (2) detailed visualization 
of a complete pancreas and topographic landmarks 
through contrast enhanced CT and MR imaging in a 
rat postmortem model; (3) to explore noninvasive MR 
imaging methods for characterization of the Caerulein 
induced acute pancreatitis in rats; (4) to estimate the 
reliability of 3D isotropic MRI and quantitative multi-
parametric MRI for characterization of an orthotopic 
pancreatic head tumor model in rats; and (5) to 
investigate therapeutic response of a vascular disrup-
tion agent in rat pancreatic tumor models with further 
modified quantitative multi-parametric methods.
Processing for quantitative parameters in rodent 
pancreatic MRI
MRI quantitative parameters can be obtained from 
advanced image processing methods using machine 
learning algorithms[35-37]. For practical considerations, 
quantitative parameters are re-generated from in-
house built Matlab programs using non-linear least 
square methods with CPU (Central Processing Unit) 
acceleration. 
T2 mapping: Traditionally, the transverse relaxation 
time T2 is obtained using multi-echo spin-echo pulse 
sequences, by sampling signals at several different 
echo-times (TE), and fitted to either multi- or single-
exponential decay functions[38]. Fast T2 mapping can be 
obtained using balanced steady-state free precession 
(SSFP) readout[39]. 
T1 mapping: On a clinical scanner, fast T1 mapping 
can be measured using inversion recovery methods 
or from variable flip angles experiments[39,40]. Since 
the MRI acquisition has to be synchronized with 
animal respiration, the effective repetition time (TR) 
is usually longer than 1 s. Thus, inversion recovery 
based protocols would be suggested for T1 mapping in 
rodent pancreatic imaging. Typically, the equation for 
measured signal in the inversion recovery T1 mapping 
experiment is a three-parameter function: SI(t) = a 
+ b × exp(-t/T1*), where SI(t) is the signal intensity 
after each inversion time t, and T1* is the effective 
longitudinal relaxation time. The actual T1 relaxation 
time can be obtained after correction for the flip 
angles[41], or the Look-Locker readout[42].
Diffusion-weighted model: In DWI experiments, 
the simple Gaussian diffusion can be assumed using 
a mono-exponential model. The two-compartment 
intravoxel incoherent motion model on the other hand 
is currently widely used in clinical pancreatitis and 
pancreatic tumor studies[43,44], and separates diffusion 
into the true-diffusion and the pseudo-diffusion fraction. 
Alternatively, sampling with high b-values above 1000 
s/mm2 can be applied for non-Gaussian diffusion 
estimation using a diffusion kurtosis model[45]. 
Post-processing for DCE model: The first step in 
DCE data post-processing is the conversion of the raw 
MRI signal to the tissue concentration time curve (CTC). 
The tissue concentration Ct of contrast agent (CA) 
during the DCE perfusion experiment is solved as: 1/T1(t) 
= 1/T10 + r1 × Ct(t), where T10 is the T1 value before 
contrast injection, obtained from inversion recovery 
T1 mapping, and r1 is the longitudinal relativity of 
the applied CA. In a high temporal resolution DCE 
experiment, the T1 relaxation T1(t) after CA injection 
can be converted from the signal intensity (SI) time 
curve as described previously[33]. Alternatively, CTC 
information can be directly extracted from the dynamic 
T1 mapping. 
The vascular input function (VIF) Cp is determined 
by the CA concentration in blood Cb: Cp = Cb/(1 - 
Hct), which is obtained from CTC of the aorta or a 
major vein, and the hematocrit level Hct which is set 
to 42% in our studies. VIF is usually fitted into a bi-
exponential function for further kinetic modeling. 
Perfusion indices, the transfer coefficient Ktrans and 
the rate constant kep, can be obtained from the 
standard or the modified Tofts model[46]. In practice, 
the discrete convolution can be constructed as a matrix 
multiplication. The fraction volume ve of extravascular 
extracellular space is calculated as: ve = Ktrans/kep.
CONCLUSION
The diagnosis of pancreatic diseases and their 
management have been largely facilitated by ever 
advancing multimodal and multi-parametric imaging 
technologies in clinical settings. Likewise, thanks to 
the above-mentioned efforts, preclinical research 
on rodent models of pancreatic pathologies are also 
rapidly progressing in terms of visual identification 
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of rodent pancreas on 2D and 3D images, imaging 
characterization of common pancreatic disorders 
such as pancreatitis and pancreatic malignancies, 
and noninvasive imaging follow-up of investigative 
therapies for new drug development. Eventually clinical 
practices in patients suffering from those often deadly 
diseases on this complex visceral organ of pancreas 
will benefit from all these translational studies.
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